Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariam Alamgir

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Drug Design, Development and Therapy|April 6, 2026
Efimosfermin for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH): Mechanism of Action, Clinical Development and Emerging Therapeutic PotentialMariam Alamgir, Aalam Sohal, Kris V Kowdley
Hepatology International|May 8, 2026
New therapies for primary biliary cholangitisAalam Sohal, Mariam Alamgir, Kris V Kowdley
Gastroenterology & Hepatology|July 2, 2026
A Review of Therapies for Primary Biliary CholangitisMariam Alamgir, Sheena Bhushan, Aalam Sohal, et al.
Gastroenterology Research|May 18, 2026
Burden and Impact of Pneumococcal Pneumonia on Outcomes in Patients With Cirrhosis: A Nationwide AnalysisMariam Alamgir, Nishma Dhand, Isha Kohli, et al.
Medicine|June 9, 2026
Rural-urban disparities in acute pancreatitis outcomes: A retrospective cohort study using the National Inpatient Sample (2016-2021)Fatima Rashid, Kasim Syed Jafri, Niloy Ghosh, et al.
Cureus|July 13, 2026
The Gastro-Circadian Metabolic Axis: A Comprehensive Framework for Chronotherapy in GastroenterologyMohammed Alkhaldi, Alejandra Felix Vicente, Victoria Fansey, et al.
Cureus|May 12, 2025
Systemic Sclerosis and Primary Biliary Cholangitis: A Comprehensive Review of Two Overlapping Rare Entities With Insights on Diagnostics and ManagementHemang H Thakkar, Nissy V Mathew, Etikala P Reddy, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Drug Design, Development and Therapy|April 6, 2026
Efimosfermin for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH): Mechanism of Action, Clinical Development and Emerging Therapeutic PotentialMariam Alamgir, Aalam Sohal, Kris V Kowdley
Hepatology International|May 8, 2026
New therapies for primary biliary cholangitisAalam Sohal, Mariam Alamgir, Kris V Kowdley
Gastroenterology & Hepatology|July 2, 2026
A Review of Therapies for Primary Biliary CholangitisMariam Alamgir, Sheena Bhushan, Aalam Sohal, et al.
Gastroenterology Research|May 18, 2026
Burden and Impact of Pneumococcal Pneumonia on Outcomes in Patients With Cirrhosis: A Nationwide AnalysisMariam Alamgir, Nishma Dhand, Isha Kohli, et al.
Medicine|June 9, 2026
Rural-urban disparities in acute pancreatitis outcomes: A retrospective cohort study using the National Inpatient Sample (2016-2021)Fatima Rashid, Kasim Syed Jafri, Niloy Ghosh, et al.
Cureus|July 13, 2026
The Gastro-Circadian Metabolic Axis: A Comprehensive Framework for Chronotherapy in GastroenterologyMohammed Alkhaldi, Alejandra Felix Vicente, Victoria Fansey, et al.
Cureus|May 12, 2025
Systemic Sclerosis and Primary Biliary Cholangitis: A Comprehensive Review of Two Overlapping Rare Entities With Insights on Diagnostics and ManagementHemang H Thakkar, Nissy V Mathew, Etikala P Reddy, et al.
Pageof 1